4.5 Review

Pharmaceutical regulation of telomerase and its clinical potential

期刊

出版社

WILEY
DOI: 10.1111/j.1582-4934.2011.01460.x

关键词

telomerase; pharmacological activators; inhibitors; natural compounds

资金

  1. IU Simon Cancer Center (IUSCC)
  2. NIH [T32 HL007910]
  3. Indiana Genomics Initiative (INGEN)
  4. Lilly Endowment, Inc.

向作者/读者索取更多资源

Telomeres serve the dual function of protecting chromosomes from genomic instability as well as protecting the ends of chromosomes from DNA damage machinery. The enzyme responsible for telomere maintenance is telomerase, an enzyme capable of reverse transcription. Telomerase activity is typically limited to specific cell types. However, telomerase activation in somatic cells serves as a key step toward cell immortalization and cancer. Targeting telomerase serves as a potential cancer treatment with significant therapeutic benefits. Beyond targeting cancers by inhibiting telomerase. manipulating the regulation of telomerase may also provide therapeutic benefit to other ailments, such as those related to aging. This review will introduce human telomeres and telomerase and discuss pharmacological regulation of telomerase, including telomerase inhibitors and activators, and their use in human diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据